hsa-mir-5094: Hsa-mir-5094 is a microRNA that was found to be the most up-regulated in the sepsis-induced acute kidney injury (AKI) group compared to the sepsis-non AKI group [PMC5351858]. Nilotinib, a drug, was found to significantly alter a number of ubiquitination genes and ubiquitin ligases, including NEDD4 and UBEs, as well as deubiquitination genes and ubiquitin-specific proteases [PMC8589263]. The relative expression of hsa-mir-5094 was determined by normalizing it to endogenously control RNU6B [PMC7554876]. Hsa-mir-5094 was found to be negatively correlated with cotinine levels in current smokers [PMC7554876]. In a larger study, hsa-mir-5094 was assessed by qPCR along with three other miRNAs (hsa-miR-3613-5p, hsa-miR-3921, and hsa-miR-337-3p) [PMC7554876]. In current smokers, except for one up-regulated miRNA (hsa-miR-3620-5p), all other miRNAs including hsa-mir-5094 were decreased [PMC7554876]. Hsa-mir-5094 along with other miRNAs such as hsa-mir96 and hsa-mir651 were found to be completely downregulated in MG (myasthenia gravis) [PMC7393356].